Medicus Pharma Reports Phase 2 Results for Skin Cancer Patch
PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported topline results from a Phase 2 clinical trial evaluating a dissolvable microneedle patch designed to deliver chemotherapy directly into basal cell …
Medicus Pharma Reports Phase 2 Results for Skin Cancer Patch Read More